CoChat

Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity

Open access
Cancado, Rodolfo Delfini, Leite, Lauro Augusto Caetano, Muñoz, Manuel · 2025 · Diagnostics

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 62 of the 125 sources its claims cite were checked for support.

Abstract

Iron deficiency (ID) is a critical public health issue globally and the most prevalent cause of anemia. Iron deficiency anemia (IDA) affects approximately 1.2 billion individuals worldwide, and it is estimated that non-anemic iron deficiency (NAID) is at least twice as common as IDA. Yet, there is still uncertainty about how to diagnose it in clinical practice. The serum ferritin (SF) threshold of <15 ng/mL proposed by the World Health Organization (WHO) has been questioned over the last decade. The current SF thresholds are inappropriately low, and, therefore, a large portion of the population at the most significant risk of ID remain undiagnosed and untreated. The correlation between SF, hepcidin, and the physiological upregulation of iron absorption in healthy adults suggests that SF of <50 ng/mL indicates a more precise threshold for diagnosing ID in adults. Therefore, adopting the SF threshold <50 ng/mL would break up the perpetuation of an inequitable cycle of disadvantage for ID individuals, especially among women.

Overview

CoChat Summary

TL;DR

This review argues that current serum ferritin (SF) thresholds for iron deficiency (ID), especially WHO’s <15 ng/mL, are inappropriately low and miss many affected individuals. It proposes adopting an SF threshold <50 ng/mL for adults, citing physiological evidence that iron absorption upregulation begins below approximately 50 ng/mL.

Key findings

  • The WHO defines ID as SF <15 ng/mL (or <70 ng/mL with infection/inflammation), but the paper states this may overlook up to 50% of patients with ID, particularly premenopausal women.
  • In a pooled analysis of stable iron isotope studies in healthy women (n = 1058), iron absorption increased below an SF threshold of 51.1 ng/mL and a hepcidin threshold of 3.09 nmol/L, supporting an SF cutoff of <50 ng/mL.
  • In the EMPIRE study of 7980 adults in mainland Portugal, the proportion of IDA among anemic individuals varied by SF cutoff: 29.0% (<15 ng/mL), 54.8% (<30 ng/mL), 75.4% (<50 ng/mL), and 92.5% (<100 ng/mL).
  • In the HEIRS cohort of 62,685 US and Canadian women, ID prevalence increased across definitions: 3.12% (SF <15 plus TSAT <10%), 7.43% (SF <15), and 15.33% (SF <25); among women aged 25–54, prevalence was 4.46%, 10.57%, and 21.23%, respectively.

Methods

  • This is a narrative review/commentary; no formal methods section, systematic search strategy, or primary data collection is described.
  • It synthesizes published evidence from cohort studies, meta-analyses, guidelines, and physiological studies, including data from HEIRS, NHANES, EMPIRE, blood donor studies, pregnancy studies, and surgical cohorts.
  • The main analysis is a narrative synthesis of SF thresholds, hepcidin, iron absorption, and prevalence estimates across populations.

Limitations

  • Stated: the paper notes that well-designed prospective clinical trials are crucial and that a recent WHO review highlighted the need for further investigation to establish a higher SF cutoff.
  • Evident: as a narrative review, it does not use a systematic search or formal quality appraisal, and its recommendation of <50 ng/mL relies on selected studies and expert interpretation.
  • Evident: the paper acknowledges concern that raising the cutoff would define nearly half of all females and approximately 14% of males as ID, but does not resolve potential overdiagnosis or resource implications with primary data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/diagnostics15030289

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

44 Valid · 7 Not valid · 15 Not checked · 4 Own results and interpretations

19 more claims · 16 with their cited sources checked

Create a free account to see all 70 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 38

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 38 references

Cited by

Metadata

Authors
Cancado, R. D., Leite, L. A. C., & Muñoz, M.
Affiliations
  • Department of Hematology, Faculdade de Ciências Médicas da Santa Casa de Sao Paulo, Sao Paulo 01224-001, Brazil
  • Hospital Samaritano de São Paulo (BR)
  • Peri-Operative Transfusion Medicine, School of Medicine, 29010 Malaga, Spain
Venue
Diagnostics
Publisher
MDPI AG
Published
2025-01-26
Volume
15
Issue
3
Pages
289
ISSN
2075-4418 (ISSN-L)
OpenAlex
W4406874221
Cited by
19
References
38
Citations by year
2026: 17 · 2025: 2
FWCI
3.20
Type
journal article
Language
en
Open access
Locations
  • Diagnostics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
CSL Vifor
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
iron deficiency, serum ferritin, diagnostic thresholds, iron deficiency anemia, non-anemic iron deficiency, hepcidin, iron absorption, health equity, women's health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.